Dr. Jose F. Cardona, JD, MBA, MHA
Doctor of Medicine, Juris Doctor Degree, MBA, MHA
Dr. Jose F. Cardona is a distinguished Medical Doctor certified by the Florida Department of Health, boasting an impressive career that spans over 30 years. His extensive experience equips him with a deep understanding of the complexities and challenges inherent in healthcare.
In addition to his medical qualifications, Dr. Cardona is also a lawyer, bringing a unique legal perspective to his practice. He has further enhanced his expertise by obtaining a Master in Business Administration (MBA) as well as a Master in Healthcare Administration, allowing him to merge his medical and legal knowledge with effective management strategies in healthcare settings.
Dr. Cardona is driven to leverage his wealth of knowledge and experience to positively impact his community. He is dedicated to providing up-to-date information that influences public health, ensuring that individuals have access to the latest developments in drugs and treatments. His commitment to lifelong learning and professional development is evident in his continuous pursuit of knowledge and his proactive approach to staying informed about advancements in the medical field.
As an Emergency Medicine Specialist, Dr. Cardona is adept at diagnosing and treating patients facing life-threatening conditions. His expertise encompasses a wide range of critical situations, including heart attacks, drug overdoses, shock, and massive bleeding. His ability to remain calm and decisive in high-pressure environments is a testament to his training and experience, making him a vital asset in any emergency situation.
Dr. Cardona’s accomplishments, research, and publications highlight his dedication to both the medical and legal professions.
Accomplishments
Fellow of the American Board of Hospital Physicians (FABHP)
Master of the American Board of Hospital Physicians (MABHP)
Master of the American Board of Ethical Physicians (MACEP)
Fellow of the American College of Legal Medicine (FACLM)
Advanced Cardiovascular Life Support (ACLS)
Research and Publications
- Merck Announces U.S. FDA Approval of VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine)
- Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
- Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial
- The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial
- Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial
- Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial
- A phase 3 randomized safety and immunogenicity trial of mRNA-1010